Summary EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare IT company that offers development of software solutions for the medical diagnostic market. The company’s software solutions include EXINIbone, EXINIheart, EXINIbrain and EXINIdat. Its EXINIbone is used in analysis of bone scintigraphy; and EXINIheart provides analysis of myocardial perfusion scintigraphy. EXINI’s EXINIbrain is used for diagnosing dementia by processing cerebral blood flow scans; and EXINIdat is used for diagnosing Parkinsonian syndromes using quantification of striatal uptake. The company provides image analysis, display of images, pre-selection of hotspot, bone scan index and qualification, Bone scan index report, handling of large databases, and artificial neural networks for increasing accuracy and improving clinical time-flow. It offers products in the fields of oncology, cardiology, and neurology. The company serves in quality, patenting, marketing and publicizing. EXINI is headquartered in Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company EXINI Diagnostics AB - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
UK In Vitro Diagnostics Industry 2019-2023: Supplier Shares by Test, Segment Volume and Sales Forecasts, Instrumentation Review, Opportunities for Suppliers This new report provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well...
2019-2023 German IVD Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure This new report provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well...
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.Contains 11 pages and 3 tables
The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
The Global Cancer Diagnostics Partnering 2012-2018 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by...
The report presents a detailed analysis of the Legionella diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Legionella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
This report provides a worldwide overview of the transfusion testing market, including estimates of facilities performing transfusion testing tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.Contains 15 pages and 5 tables
This new report from VPGMarketResearch.com provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents:Estimated numbers of cancer testing laboratories, as well as...
This new study from VPGMarketResearch.com contains 1,013 pages, 62 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.